期刊文献+

中国复治肺结核不良治疗结局危险因素的Meta分析 被引量:6

Risk Factors of Retreatment Pulmonary Tuberculosis Patients with Unfavorable Treatment Outcome in China:A Meta-analysis
原文传递
导出
摘要 目的系统评价复治肺结核治疗发生不良结局的影响因素。方法计算机检索CNKI、VIP、CBM和Wan Fang Data数据库,搜集关于复治肺结核治疗发生不良结局影响因素的研究,检索时限均为从建库至2015年11月15日。由2位评价员独立筛选文献、提取资料并评价纳入研究的偏倚风险后,采用Rev Man 5.3软件进行Meta分析。结果最终纳入13个研究。Meta分析结果显示:在单因素分析中,标准复治方案[OR=4.98,95%CI(2.95,8.39),P<0.000 01]、耐药[OR=4.22,95%CI(1.85,9.63),P=0.000 6]、耐多药[OR=7.19,95%CI(2.51,20.58),P=0.000 2]、肺部有空洞[OR=1.80,95%CI(1.20,2.71),P=0.005]、合并糖尿病[OR=2.05,95%CI(1.30,3.22),P=0.002]、痰菌含量[OR=2.07,95%CI(1.30,3.29),P=0.002]与复治肺结核不良治疗结局相关;在多因素分析中,合并糖尿病[OR=3.38,95%CI(1.56,7.29),P=0.002]与复治肺结核不良治疗结局相关。结论现有证据表明,合并糖尿病、标准复治方案、耐药、耐多药、肺部有空洞、痰菌含量>2+均是复治肺结核患者治疗发生不良结局的危险因素,尤其对于合并糖尿病的患者需要加强管理,从而降低复治失败率。受纳入研究数量和质量的限制,上述结论尚待进一步开展更多高质量的研究加以验证。 Objective To systematically review the risk factors of retreatment pulmonary tuberculosis with unfavorable treatment outcome. Methods We electronically searched databases including CNKI, VIP, CBM and WanFang Date from inception to November 15th 2015, to collect studies about the risk factors of retreatment pulmonary tuberculosis patients with unfavorable treatment outcome. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Then, meta-analysis was conducted using RevMan 5.3 software. Results A total of 13 studies were included. The results of meta-analysis showed that significant association was found between retreatment pulmonary tuberculosis cases with unfavorable treatment outcome and such factors as the standard retreatment regimen (OR=4.98, 95%CI 2.95 to 8.39, P〈0.000 01), drug-resistance (OR=4.22, 95%CI 1.85 to 9.63, P=0.000 6), multi-drug resistance (OR=7.19, 95%CI 2.51 to 20.58, P=0.000 2), status of cavitas (OR=1.80, 95%CI 1.20 to 2.71, P=0.005), TB-diabetes mellitus (OR=2.05, 95%CI 1.30 to 3.22, P=0.002) and high sputum smear load 〉2+ (OR=2.07, 95%CI 1.30 to 3.29, P=0.002) in univariate-analysis, respectively. But, in multivariate-analysis, only TB- diabetes mellitus (OR=3.38, 95%C! 1.56 to 7.29, P=0.002) showed significant association with retreatment pulmonary tuberculosis cases with unfavorable treatment outcome. Conclusion Current evidence shows that TB-diabetes mellitus, standard retreatment regimen, drug-resistance, multi-drug resistance, status of cavitas and high sputum smear load 〉2+are considered to be the risk factors for retreatment pulmonary tuberculosis cases with unfavorable treatment outcome. Especially, for patients with diabetes, the importance of management need to be reinforced to reduce the failure rate in the retreatment of pulmonary tuberculosis. Due to limited quality and quantity of the included studies, more high quality studies are needed to verify the above conclusion.
出处 《中国循证医学杂志》 CSCD 2016年第7期795-801,共7页 Chinese Journal of Evidence-based Medicine
基金 内蒙古自治区教育厅自然科学重大项目(编号:NJZZ14152)
关键词 结核 复治 不良结局 治疗失败 META分析 Tuberculosis, pulmonary Retreatment Unfavorable treatment outcome Treatment failure Meta-analysis
  • 相关文献

参考文献43

  • 1World Health Organization. Global Tuberculosis Report 2015. Geneva: WHO, 2015: 1-149.
  • 2Reis-Santos B, Gomes T, Locatelli R, et al. Treatment outcomes in tuberculosis patients with diabetes: a polytomous analysis using Brazilian surveillance system. PLoS One, 2014, 9(7): e100082.
  • 3Kritski AL, Rodrigues de Jesus LS, Andrade MK, et al. Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes. Chest, 1997, 111(5): 1162-1167.
  • 4Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta- analyses. Eur] Epidemiol, 2010, 25(9): 603-605.
  • 5Higgins J, Green S. Cochrane handbook for systematic reviews of interventions versionS.0.0 [update February 2008]. The Cochrane Collaboration, 2008.Available at: www.cochrane-handbook.org.
  • 6韩旻雁,银恭举,陈维清.中国人群鼻咽癌发病危险因素的Meta分析[J].中国热带医学,2005,5(7):1442-1443. 被引量:8
  • 7Hamling J, Lee P, Weitkunat R, et al. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Star Med, 2008, 27(7): 954-970.
  • 8陈长生,徐勇勇.第十四讲 如何进行meta分析[J].中华预防医学杂志,2003,37(2):138-140. 被引量:91
  • 9黄勇.2003-2007年阿坝州涂阳肺结核发现和治疗分析[J].寄生虫病与感染性疾病,2008,6(4):193-196. 被引量:1
  • 10唐恒发.213例复治涂阳肺结核病例转归的影响因素分析[J].安徽预防医学杂志,2008,14(4):250-252. 被引量:1

二级参考文献117

共引文献207

同被引文献76

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部